Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ainos Inc (AIMD)

Ainos Inc (AIMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
RedChip AI Investor Conference Replays Now Available Featuring Public Companies Across the Artificial Intelligence Value Chain

ORLANDO, FL / ACCESS Newswire / March 26, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced that on-demand replays...

AIMD : 1.3900 (+2.96%)
BFRG : 1.6800 (+60.00%)
GRRR : 10.53 (+10.49%)
SUUN : 0.5354 (+6.55%)
BESS : 2.13 (-2.07%)
RedChip Showcases Public Companies Across the Artificial Intelligence Value Chain at March 19 Virtual Investor Conference

ORLANDO, FL / ACCESS Newswire / March 9, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming AI Investor...

AIMD : 1.3900 (+2.96%)
BFRG : 1.6800 (+60.00%)
GRRR : 10.53 (+10.49%)
SUUN : 0.5354 (+6.55%)
BESS : 2.13 (-2.07%)
Ainos Down on NEXCOM Hookup

Ainos, Inc. (NASDAQ:AIMD) shares decreased first thing Tuesday. The company, purporting to be a leader ...

AIMD : 1.3900 (+2.96%)
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V.

Show Number 675 is sponsored programming by Ainos (NASDAQ: AIMD), Arrive AI ($ARAI), Acurx Pharmaceuticals (NASDAQ: ACXP), Sustainable Green Team (OTC: SGTM) and Commercialville T.V. commercials

AIMD : 1.3900 (+2.96%)
ACXP : 3.71 (+6.00%)
BIVI : 1.4000 (+3.70%)
SGTM : 0.3125 (+31.19%)
AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street

Strategic media partnership will amplify AINOS's brand and innovation story across major financial networks and digital platforms

AIMD : 1.3900 (+2.96%)
Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / May 2, 2025 / RedChip Companies will air interviews with Atossa Therapeutics, Inc. (Nasdaq:ATOS) and Ainos, Inc. (Nasdaq:AIMD) on the RedChip Small Stocks, Big Money™...

AIMD : 1.3900 (+2.96%)
ATOS : 5.26 (+11.68%)
Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing

Expanding AI Nose's Commercial Opportunity for Smarter, Safer, and More Sustainable Factories

AIMD : 1.3900 (+2.96%)
AIMDW : 0.1158 (+2.03%)
Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly

Robotic smelltech by AI Nose moves from concept to integration in weeks

AIMD : 1.3900 (+2.96%)
AIMDW : 0.1158 (+2.03%)
Ainos and ugo Complete First Robotic Smell Integration in Japan

Milestone Ignites a New Era of Smell-Enabled Robotics

AIMD : 1.3900 (+2.96%)
AIMDW : 0.1158 (+2.03%)
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

Dual Trials Accelerate VELDONA® Toward Rare Disease Market Entry

AIMD : 1.3900 (+2.96%)
AIMDW : 0.1158 (+2.03%)

Barchart Exclusives

This Dividend King Is Down 26%. When Will It Bounce Back?
Abbott Laboratories is down 26% from its 52-week high due to a soft quarter. With 54 consecutive years of dividend hikes and guidance calling for mid-single-digit organic sales growth plus 10% EPS expansion, the Dividend King seems discounted, but the question is, can it rebound? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.